In this article, we are going to take a look at where Johnson Controls International plc (NYSE:JCI) stands against the other stocks Jim Cramer recently talked about. Investors are pulling back ...

The Johnson Controls Inc. operational headquarters in Glendale. Learn more about: Johnson Controls Julie Brandt Nathan Manning Johnson Controls plc, which has its operating headquarters in ...

Let's talk about the popular Johnson Controls International plc (NYSE:JCI). The company's shares received a lot of attention from a substantial price movement on the NYSE over the last few months ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Speaker Mike Johnson is replacing Rep. Mike Turner as chairman of the House Intelligence Committee after a debacle that started with a warning about Russian space nuclear technology last year ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

Anti-aging advocate Bryan Johnson, who gulps down 54 pills for breakfast, recently discovered a wrinkle in his meticulous approach to dodging death. Every two weeks, the 47-year-old tech ...

Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

The Houston Texans on Tuesday waived wide receiver Diontae Johnson as they prepare for their divisional-round playoff game on Saturday against the Kansas City Chiefs. "Unfortunately, with Diontae ...